Clinical Trials Logo

Clinical Trial Summary

BIOCOR is an interventional clinical trial whose main objectives are Objectif are identify molecular biomarker(s) of ocular rosacea and pachychoroid. Endpoints are : Correlation between pachychoroidosis (defined by choroidal phenotype parameters in OCT and autofluorescence) or the stage of ocular rosacea (ROSCO(29) definition) and biological markers selected on the basis of preclinical work (animal model) and by unbiased methods (proteomics, metabolomics, meibum lipidomics). The study of circulating, ocular and functional biomarkers would enable us to confirm our hypothesis and identify patients who could benefit from treatments that regulate the ANS and/or mineralocorticoid pathways.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06466018
Study type Interventional
Source Clinact
Contact CRA
Phone + 3315 841 28 98
Email contact@multihealthgroup.com
Status Recruiting
Phase N/A
Start date March 19, 2024
Completion date October 1, 2026

See also
  Status Clinical Trial Phase
Completed NCT02066051 - IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD N/A
Completed NCT03655197 - Lipidome and Microbiome Profile of the Eye in Rosacea Early Phase 1
Withdrawn NCT04839549 - Efficacy and Safety of Dextenza Compared to Topical Fluorometholone in Patients With Ocular Rosacea Phase 4
Recruiting NCT05296837 - Ocular Rosacea Biome Study Phase 4
Not yet recruiting NCT04025801 - Heidelberg In Vivo Confocal Microscopy to Evaluate the Ocular Surface Disorders of Healthy and Diseased Individuals
Completed NCT03194698 - Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea N/A
Completed NCT03479853 - Clinical, Meibographic and Interferometric Evaluation of Phlyctenular Keratitis in Children - MEIBO-ROSACEE